Martin Hulsmann
Overview
Explore the profile of Martin Hulsmann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
133
Citations
1813
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Prausmuller S, Wurm R, Ponleitner M, Stogmann E, Hulsmann M, Pavo N
J Card Fail
. 2025 Feb;
PMID: 40021046
Background: Sacubitril/valsartan is a key therapy for heart failure with reduced ejection fraction (HFrEF). However, concerns remain regarding its potential impact on cognitive function since neprilysin inhibition may influence amyloid-β...
2.
Bavendiek U, Berliner D, Thomas N, Liu X, Schwab J, Rieth A, et al.
Eur J Heart Fail
. 2025 Jan;
PMID: 39838553
No abstract available.
3.
Greene S, Bohm M, Bozkurt B, Butler J, Cleland J, Coats A, et al.
J Card Fail
. 2024 Sep;
PMID: 39277029
Background: Despite guideline recommendations, many patients with heart failure (HF) do not receive target dosages of renin-angiotensin-aldosterone system inhibitors (RAASis) in clinical practice due, in part, to concerns about hyperkalemia...
4.
Hofer-Zeni S, Leutner M, Klimek P, Bellach L, Pavo N, Prausmuller S, et al.
Cardiovasc Diabetol
. 2024 Aug;
23(1):280.
PMID: 39090699
Objectives: This study aimed to assess the guideline recommended diagnostic tools NT-proBNP and NYHA classification, with a focus on sex-specific differences. Background: Patients with Type 2 Diabetes (T2D) face a...
5.
Heitzinger G, Spinka G, Prausmuller S, Pavo N, Dannenberg V, Dona C, et al.
JACC Adv
. 2024 Jun;
1(3):100063.
PMID: 38938405
Background: Secondary mitral regurgitation (sMR) in the setting of heart failure (HF) has considerable impact on quality of life, HF rehospitalizations, and mortality. Identification of high-risk cohorts is essential to...
6.
Wurm R, Prausmuller S, Ponleitner M, Spinka G, Weidenhammer A, Arfsten H, et al.
JACC Heart Fail
. 2024 Jun;
12(6):1073-1085.
PMID: 38839151
Background: Cognitive impairment is prevalent in patients with heart failure with reduced ejection fraction (HFrEF), affecting self-care and outcomes. Novel blood-based biomarkers have emerged as potential diagnostic tools for neurodegeneration....
7.
Arfsten H, Heitzinger G, Prausmuller S, Weidenhammer A, Goliasch G, Bartko P, et al.
ESC Heart Fail
. 2024 Mar;
11(3):1748-1757.
PMID: 38459668
Aims: Regulation of the renin-angiotensin system (RAS) in heart failure (HF) with reduced ejection fraction (HFrEF) still raises questions, as a large proportion of patients show normal renin levels despite...
8.
Panagiotides N, Poledniczek M, Andreas M, Hulsmann M, Kocher A, Kopp C, et al.
Viruses
. 2024 Jan;
16(1).
PMID: 38257821
Microvascular integrity is a critical factor in myocardial fluid homeostasis. The subtle equilibrium between capillary filtration and lymphatic fluid removal is disturbed during pathological processes leading to inflammation, but also...
9.
Weidenhammer A, Prausmuller S, Partsch C, Spinka G, Luckerbauer B, Larch M, et al.
Cells
. 2023 Dec;
12(24).
PMID: 38132152
Background: CILP-1 regulates myocardial fibrotic response and remodeling and was reported to indicate right ventricular dysfunction (RVD) in pulmonary hypertension (PH) and heart failure (HF). This study examines CILP-1 as...
10.
Han E, Prausmuller S, Weidenhammer A, Spinka G, Arfsten H, Bartko P, et al.
J Renin Angiotensin Aldosterone Syst
. 2023 Nov;
2023:8883145.
PMID: 37941680
Introduction: The renin-angiotensin system (RAS) is the main target of neurohumoral therapy in heart failure with reduced ejection fraction (HFrEF) effectively reducing mortality. Reasonably, renin might serve as a biomarker...